Patient's with schizophrenia may exhibit positive, negative or cognitive symptoms. What would be examples of positive schizophrenic symptoms? (Select all that apply)

High-potency first-generation antipsychotics can cause rare but life-threatening adverse reactions due to profound dopamine blockade in the central nervous system. One of the most critical complications is a severe idiosyncratic reaction affecting muscle tone, autonomic function, and temperature regulation. Neuroleptic malignant syndrome presents as a rapid onset emergency requiring immediate drug discontinuation and intensive supportive care. Early recognition is essential to prevent complications such as rhabdomyolysis, renal failure, and cardiovascular collapse.

Rationale:
A. Neuroleptic malignant syndrome is characterized by hyperthermia, “lead pipe” muscle rigidity, autonomic instability (fluctuating blood pressure, dysrhythmias, diaphoresis), and altered mental status. It occurs due to severe dopamine receptor blockade in the hypothalamus and basal ganglia. This condition is a medical emergency requiring immediate discontinuation of the antipsychotic and aggressive supportive management.

B. Acute dystonia involves sudden, sustained muscle contractions such as torticollis, oculogyric crisis, or jaw spasms. It typically occurs within hours to days of starting antipsychotics and does not present with fever or autonomic instability. The systemic severity and rigidity described are not consistent with this condition.

C. Parkinsonism from antipsychotics presents with bradykinesia, rigidity, resting tremor, and masked facies. Although rigidity may occur, it develops gradually and does not include hyperthermia, severe autonomic instability, or acute life-threatening features. The presentation here is far more severe and acute than parkinsonism.

D. Extrapyramidal symptoms is a broad umbrella term that includes dystonia, akathisia, parkinsonism, and tardive dyskinesia. While neuroleptic malignant syndrome is technically related to dopamine blockade, it is a distinct, severe, and life-threatening condition rather than a typical extrapyramidal side effect. The systemic signs indicate a specific syndrome rather than a general EPS reaction.

Opioid analgesics are classified based on their activity at opioid receptors as full agonists, partial agonists, or agonist-antagonists. Agonist-antagonist opioids stimulate certain receptors while blocking others, producing analgesia with a lower risk of respiratory depression compared to full agonists. These drugs are often used in specific pain management situations or to reduce abuse potential. Understanding these classifications is essential for safe opioid selection and preventing adverse effects.

Rationale:
A. Nalbuphine is an agonist-antagonist opioid that acts as a kappa receptor agonist and a mu receptor antagonist. This dual action provides analgesia while limiting the degree of respiratory depression and euphoria. It is commonly used for moderate to severe pain and is known for having a ceiling effect on respiratory depression.

B. Pentazocine is another agonist-antagonist opioid that stimulates kappa receptors and partially blocks mu receptors. It produces analgesia but may also cause side effects such as dysphoria and hallucinations due to its receptor profile. It is classified clearly within the agonist-antagonist group.

C. Buprenorphine functions as a partial agonist at mu receptors and an antagonist at kappa receptors, placing it within the agonist-antagonist category. It is used for both pain management and opioid dependence treatment due to its ceiling effect on respiratory depression and lower abuse potential.

D. Morphine is a full opioid agonist that strongly activates mu receptors without antagonist activity. It produces potent analgesia but carries a higher risk of respiratory depression, dependence, and euphoria. Because it lacks antagonist properties, it does not belong to the agonist-antagonist class.